Speaker Faculty

Achim Obergfell

Global Medical Head Nephrology

CSL Vifor

Aliza Thompson

Deputy Director

FDA

Amit Sharma

Vice President & Head Of Clinical Development & Global Therapeutic Area Nephrology & Hematology

Alexion Pharmaceuticals

Anil Karihaloo

Senior Principal Scientist - Research

Novo Nordisk

Ankit Patel

Medical Director

Vertex Pharmaceuticals

Asim Dey

Senior Advisor, Diabetic Complication Therapeutic Area

Eli Lilly

Astrid Weins

Chief, Renal Pathology Service

Brigham and Women’s Hospital

Bhupinder Singh

Chief Medical Officer

Renibus Therapeutics

Bonnie Schneider

Founder & Executive Director

IGA Nephropathy Foundation

Carol Moreno Quinn

Head Nephrology, Global Medical Affairs

Roche

Carolina Aldworth

Senior Medical Director

Novartis

Charles Lee

Executive Director - Regulatory Affairs, Cardiovascular, Renal & Metabolism

AstraZeneca

Denis Feliers

Director - Acute Renal Failure

Pfizer

Dinah Clark

Director of Medical Education

Natera

Dominik Steubl

Senior Clinical Program Lead

Boehringer Ingelheim

Doug Paul

Board

NephKey

Edgar Jaimes

Chief of Renal Service, Department of Medicine

Weill Cornell Medical College

Eve Dryer

VP Patient Advocacy

Travere Therapeutics, Inc.

Fady Botros

Associate VP

Eli Lilly

Federica Genovese

Director - Cardiovascular & Renal Research

Nordic Bioscience

Fredrik Erlandsson

Chief Medical Officer

Purespring Therapeutics

Giorgia Jurisic Snijder

Head of Cellular Pharmacology & Imaging Zurich

CSL R&D

Hans-Joachim Anders

Professor of Nephrology

University of Munich

Hiddo Heerspink

Professor

University of Gronigan

Houston Gilbert

Vice President, Biometrics & Data Management

HI-Bio

Jacky Vonderscher

Co-Founder and Chief Executive Officer

ENYO Pharma

Jay Elliott

Executive Director, Global Medical Strategy

Otsuka

Jeffrey Hafkin

Senior Director

Otsuka

Jerome Rossert

Vice President, Head of Clinical Renal, Late CVRM

AstraZeneca

Jiahua Li

Senior Medical Director

Alpine Immune Sciences

Jonathan Barratt

Professor of Renal Medicine

University of Leicester

Karen Paraschin

Global Clinical Leader

Bayer

Katherine Garlo

Senior Medical Director

Alexion

Kathryn Garner

Head of Kidney Development

Newcells Biotech

Kelly Helm

Executive Director - Patient Engagement

NephCure

Kerry Cooper

Senior Vice President - Medical Affairs

Vera Therapeutics

Kevin Chung

Chief Medical Officer

SeaStar Medical

Kirtida Mistry

Senior Physician & Clinical Reviewer, Division of Cardiology & Nephrology

FDA

Krzysztof Kiryluk

Associate Professor of Medicine, Division of Nephrology, Department of Medicine

Columbia University

Lauren Eva

Executive Vice President, Professional Relations

NephCure

Lynne Yao

Director - Division of Pediatrics and Maternal Health

FDA

Maarten Hoek

Senior Vice President, Head of Research

Maze Therapeutics

Maria Ali

Chief Medical Officer

George Clinical

Mary Haas

Senior Manager - Cardiovascular Metabolic & Skeletal Disease Genetics

Regeneron Genetics Centre

Matthias Kretzler

Warner Lambert- Parke Davis Professor of Medicine and Bioinformatics

University of Michigan

MK Farmer

Program Lead

Takeda

Mohit Mathur

Director, Clinical Development

Visterra

Nikhil Agrawal

Global Development Medical Director

AstraZeneca

Ogo Egbuna

Vice President - Clinical Development

Vertex Pharmaceuticals

Patrick Schloemer

Principal Statistician

Bayer

Paul Hockings

Senior Imaging Director

Antaros Medical

Phil McEwan

Chief Executive Officer

Health Economics and Outcomes Research Ltd

Roberto Pecoits-Filho

Nephrologist

International Society of Nephrology

Romer Gonzalez-Villalobos

Scientific Director, Kidney Diseases

Janssen

Samvel Gasparyan

Statistical Science Associate Director

AstraZeneca

Simone Sanna-Cherchi

Associate Professor

Columbia University

Sorin Fedeles

Executive Director

C-Path

Stephen Andrews

Head of BioPharma Partnering

Natera

Stephen Elliman

Chief Scientific Officer

Orbsen Therapeutics

Steve Olson

Senior Medical Director; Renal

Novartis

Thomas Hiemstra

Fellow and Senior Director, Clinical Development

GSK

Thomas Idorn

International Medical Vice President

Novo Nordisk

Thorsten Vetter

Senior Scientific Officer

EMA

Tobias Agervald

Chief Executive Officer

Guard Therapeutics

Tom Greene

Professor of the Division of Biostatistics, Department of Population Health Sciences

University of Utah

Ulf Meier-Kriesche

Chief Scientific Officer

Veloxis Pharmaceuticals

Vishal Duggal

Associate Medical Director

Genentech

Warren Brooks

Vice President Medical Affairs

Calliditas Therapeutics

EVENT GUIDE
REGISTER
PARTNER